Tether for a capsule endoscope

- AnX Robotica Corp
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective of a tether for a capsule endoscope showing the new design;

FIG. 2 is another front perspective view thereof;

FIG. 3 is a front view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a right side view thereof;

FIG. 6 is a left side view thereof;

FIG. 7 is a top plan view thereof; and,

FIG. 8 is a bottom plan view thereof.

The dash-dash broken lines in FIG. 1 depict portions of the tether for a capsule endoscope that forms no part of the claimed design. Additionally, the appearance of any portion of the article between break lines forms no part of the claimed design.

Claims

The ornamental design for a tether for a capsule endoscope as shown and described.

Referenced Cited
U.S. Patent Documents
4195624 April 1, 1980 Douglas
4198960 April 22, 1980 Utsugi
5653677 August 5, 1997 Okada et al.
5840251 November 24, 1998 Iwak
D501549 February 1, 2005 McAllister
D560813 January 29, 2008 Matsuura
D636071 April 12, 2011 Bhatt
8235888 August 7, 2012 Kawano
8269823 September 18, 2012 Hirakawa et al.
D747791 January 19, 2016 Kaser
9339174 May 17, 2016 Gilad et al.
9392929 July 19, 2016 Bendele et al.
D827816 September 4, 2018 Newman
10070854 September 11, 2018 Duan et al.
10076234 September 18, 2018 Duan et al.
D891632 July 28, 2020 Shalon
11083365 August 10, 2021 Kim
11771311 October 3, 2023 Duan et al.
11786114 October 17, 2023 Duan
20020103417 August 1, 2002 Gazdzinski
20030013938 January 16, 2003 Iddan et al.
20030139647 July 24, 2003 Raz et al.
20040267095 December 30, 2004 Miyake et al.
20050085697 April 21, 2005 Yokoi et al.
20050267361 December 1, 2005 Younker et al.
20060193893 August 31, 2006 Brown
20060235275 October 19, 2006 Rabinovitz et al.
20070015961 January 18, 2007 Yamamoto et al.
20070049796 March 1, 2007 Fujikura
20070118018 May 24, 2007 Gilad et al.
20070260175 November 8, 2007 Segawa et al.
20070299309 December 27, 2007 Seibel et al.
20080015413 January 17, 2008 Barlow et al.
20080108866 May 8, 2008 Lin
20080115606 May 22, 2008 Suzuki
20080117291 May 22, 2008 Hirakawa et al.
20080154093 June 26, 2008 Cho et al.
20080160477 July 3, 2008 Stookey et al.
20080167523 July 10, 2008 Uchiyama et al.
20080167525 July 10, 2008 Wakefield
20080177141 July 24, 2008 Wu et al.
20090018396 January 15, 2009 Takizawa et al.
20090018398 January 15, 2009 Segawa
20090062614 March 5, 2009 Adzich et al.
20100322866 December 23, 2010 Rabinovitz
20110065987 March 17, 2011 Mullick et al.
20110144431 June 16, 2011 Graumann
20110184293 July 28, 2011 Rabinovitz et al.
20110254938 October 20, 2011 Asada et al.
20110319639 December 29, 2011 Wessig et al.
20120095391 April 19, 2012 Bendele et al.
20120101331 April 26, 2012 Gilad et al.
20120165796 June 28, 2012 Ortiz et al.
20130018224 January 17, 2013 Kim
20140206016 July 24, 2014 Lozano et al.
20140243598 August 28, 2014 Genier et al.
20150011829 January 8, 2015 Wang et al.
20160235282 August 18, 2016 Nakamura
20190099067 April 4, 2019 Tseng
20200037862 February 6, 2020 Duan et al.
20200196873 June 25, 2020 Ntziachristos et al.
20200323422 October 15, 2020 Duan
20200323433 October 15, 2020 Ming
20210353135 November 18, 2021 Choi
20220022736 January 27, 2022 Duan et al.
20240000300 January 4, 2024 Duar
Foreign Patent Documents
103113606 May 2013 CN
103304832 September 2013 CN
107064131 August 2017 CN
109813666 May 2019 CN
109924937 June 2019 CN
111202528 May 2020 CN
111808916 October 2020 CN
WO-2019/171409 September 2019 WO
Other references
  • Anx Robotics Colon Capsule System, posted at anxrobotics.com, first date unavailable, retrieved Jul. 11, 2023, online, URL: https://www.anxrobotics.com/products/navicam-colon-capsule-system/ (Year: 2023).
  • Chen, R. et al. (2006). “Quantitative Proteomic Profiling of Pancreatic Cancer Juice,” Proteomics 6:3871-3879.
  • Chinese Office Action mailed on Jun. 10, 2022, for Application No. 202010725938.5, filed on Jul. 23, 2021, 14 total pages (with English Translation).
  • Eshleman, J.R. et al. (2015). “KRAS and Guanine Nucleotide-Binding Protein Mutations in Pancreatic Juice Collected from the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound.” Clinical Gastroenterology and Hepatology 13:963-969.e4.
  • Extended European Search Report mailed on Dec. 5, 2022, for EP Application No. 20 787 566.7, filed on Apr. 9, 2020, 8 pages.
  • Farrell, J.J. et al. (2005). “Early Detection Markers in Pancreas Cancer,” Cancer Biomarkers 1:157-175.
  • Final Office Action mailed on Jul. 28, 2022, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 12 pages.
  • Fujiyama, Y. et al. (2020). “Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN),” Annals of Surgical Oncology 27:4007-4016.
  • Hayakawa, H. et al. (2019). “Carcinoembryonic Antigen Level in the Pancreatic Juice Is Effective in Malignancy Diagnosis and Prediction of Future Malignant Transformation of Intraductal Papillary Mucinous Neoplasm of the Pancreas,” Journal of Gastroenterology 54:1029-1037.
  • International Search Report mailed on Aug. 19, 2020, for PCT Application No. PCT/US2020/027422, filed on Apr. 9, 2020, 4 pages.
  • International Search Report mailed on Oct. 20, 2021, for PCT Application No. PCT/US2021/108258, filed on Jul. 23, 2021, 7 pages (with English Translation).
  • Majumder, S. et al. (2020). “Methylated DNA in Pancreatic Juice Distinguishes Patients with Pancreatic Cancer from Controls,” Clinical Gastroenterology and Hepatology 18:676-683.e3.
  • Majumder, S. et al. (2019). “Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing,” The American Journal of Gastroenterology 114:1539-1549.
  • Mori, Y. et al. (2013). “A Minimally Invasive and Simple Screening Test for Detection of Pancreatic Ductal Adenocarcinoma Using Biomarkers in Duodenal Juice,” Pancreas 42:187-192.
  • Nakamura, S. et al. (2019). “Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma,” Annals of Surgical Oncology 26:2104-2111.
  • Nakashima, A. et al. (2009). “Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic Malignancy,” Pancreas 38:527-533.
  • Non-Final Office Action mailed on Jan. 31, 2022, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 11 pages.
  • Non-Final Office Action mailed on Sep. 6, 2022, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 11 pages.
  • Non-Final Office Action mailed on Jan. 23, 2023, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 12 pages.
  • Non-Final Office Action mailed on Feb. 6, 2023, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 13 pages.
  • Singhi, A.D et al. (2018). “Preoperative Next-Generation Sequencing of Pancreatic Cyst Fluid Is Highly Accurate in Cyst Classification and Detection of Advanced Neoplasia,” Gut 67:2131-2141.
  • Springer, S. et al. (2015). “A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts,” Gastroenterology 149:1501-1510.
  • Tanaka, M. et al. (2019). “Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review,” Clinical Gastroenterology and Hepatology 17:2199-2211.e21.
  • Tian, T. et al. (2017). “Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies,” Oxidative Medicine and Cellular Longevity 2017:4535194.
  • Tobi, M. et al. (2013). “Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma,” Digestive Diseases and Sciences 58:744-750.
  • Wang, J. et al. (2014). “Circulating MicroRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer,” Journal of Cancer 5:696-705.
  • Written Opinion of the International Searching Authority mailed on Aug. 19, 2020, for PCT Application No. PCT/US2020/027422, filed on Apr. 9, 2020, 9 pages.
  • Yu, J. et al. (2017). “Digital Next-Generation Sequencing Identifies Low-Abundance Mutations in Pancreatic Juice Samples Collected from the Duodenum of Patients with Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms,” Gut 66:1677-1687.
  • Zhao, X.-R. et al. (2016). “Highly sensitive fluorescence detection of trypsin based on gold nanoparticle probes,” Anal. Methods 8:393-400.
  • Notice of Allowance mailed on Aug. 10, 2023, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 7 pages.
  • Notice of Allowance mailed on Jun. 8, 2023, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 8 pages.
Patent History
Patent number: D1060669
Type: Grant
Filed: Apr 9, 2019
Date of Patent: Feb 4, 2025
Assignee: AnX Robotica Corp (Plano, TX)
Inventor: Xiaodong Duan (Pleasanton, CA)
Primary Examiner: Jennifer L Rempfer
Assistant Examiner: Michelle Marquart Christeon
Application Number: 29/686,956